WallStreetZenWallStreetZen

NASDAQ: MGX
Metagenomi Therapeutics Inc Stock Ownership - Who owns Metagenomi Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Metagenomi Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Matthew WeinTitle General Counsel Compliance Officer and Corporate Secretary2026-06-05558$1.30
$724.84Sell
Pamela WapnickChief Financial Officer2026-06-052,884$1.30
$3.75kSell
Jian IrishPresident and Chief Executive Officer2026-06-053,737$1.30
$4.85kSell
Matthew WeinTitle General Counsel Compliance Officer and Corporate Secretary2026-03-05482$1.60
$771.20Sell
Pamela WapnickChief Financial Officer2026-03-051,581$1.60
$2.53kSell
Jian IrishChief Executive Officer2026-03-051,607$1.60
$2.57kSell
Matthew WeinTitle General Counsel Compliance Officer and Corporate Secretary2025-12-05199$1.77
$352.63Sell
Jian IrishChief Executive Officer2025-12-051,602$1.77
$2.84kSell
Brian C. ThomasDirector2025-12-053,830$1.77
$6.79kSell
Pamela WapnickChief Financial Officer2025-12-051,576$1.77
$2.79kSell

1 of 2

MGX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MGX insiders and whales buy or sell their stock.

MGX Shareholders

What type of owners hold Metagenomi Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bayer Healthcare LLC10.72%4,050,997$4.98MInsider
Sebastian Bernales8.12%3,068,786$3.77MInsider
Brian C. Thomas6.65%2,510,960$3.09MInsider
Holdings A. Novo4.60%1,739,175$2.14MInsider
Jian Irish1.77%670,246$824.40kInsider
Pamela Wapnick0.55%208,491$256.44kInsider
Matthew Wein0.33%126,491$155.58kInsider
Simon Harnest0.32%122,664$150.88kInsider
Sarah B. Noonberg0.29%109,135$134.24kInsider
Simren Delaney0.25%93,892$115.49kInsider

1 of 3

MGX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MGX0.02%33.94%Net BuyingNet Selling
VERU0.01%99.99%
KPTI0.06%99.94%Net SellingNet Selling
GRCE0.02%33.48%
MCRB0.00%100.00%Net SellingNet Selling
View Top Biotech Stocks

Metagenomi Therapeutics Stock Ownership FAQ

Who owns Metagenomi Therapeutics?

Metagenomi Therapeutics (NASDAQ: MGX) is owned by 0.02% institutional shareholders, 33.94% Metagenomi Therapeutics insiders, and 66.04% retail investors. Bayer Healthcare LLC is the largest individual Metagenomi Therapeutics shareholder, owning 4.05M shares representing 10.72% of the company. Bayer Healthcare LLC's Metagenomi Therapeutics shares are currently valued at $4.98M.

If you're new to stock investing, here's how to buy Metagenomi Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.